2-(3-Fluorophenyl)-4-[(3S)-piperidin-3-ylamino]thieno[3,2-c]pyridine-7-carboxamide

ID: ALA4098878

PubChem CID: 11951723

Max Phase: Preclinical

Molecular Formula: C19H19FN4OS

Molecular Weight: 370.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NC(=O)c1cnc(N[C@H]2CCCNC2)c2cc(-c3cccc(F)c3)sc12

Standard InChI:  InChI=1S/C19H19FN4OS/c20-12-4-1-3-11(7-12)16-8-14-17(26-16)15(18(21)25)10-23-19(14)24-13-5-2-6-22-9-13/h1,3-4,7-8,10,13,22H,2,5-6,9H2,(H2,21,25)(H,23,24)/t13-/m0/s1

Standard InChI Key:  YTDCGNUVVIXLSO-ZDUSSCGKSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   37.5382   -3.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5353   -5.4218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5408   -2.9655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2539   -2.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9626   -2.9746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6735   -2.5676    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.6804   -1.7460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9700   -1.3329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2528   -1.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5378   -6.2431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8272   -6.6538    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2508   -6.6495    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2421   -4.1925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2401   -5.0078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0149   -5.2618    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   39.4959   -4.6033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0182   -3.9425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3131   -4.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7143   -5.3145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5307   -5.3169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9418   -4.6097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5306   -3.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7155   -3.8997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8255   -5.0169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8212   -4.1997    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9384   -3.1904    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 14  2  1  0
 13  1  1  0
  1 25  2  0
  1  3  1  0
  4  3  1  1
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  1  0
 10 12  2  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  2 24  2  0
 24 25  1  0
 22 26  1  0
M  END

Associated Targets(Human)

CHEK1 Tchem Serine/threonine-protein kinase Chk1 (6846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW-620 (52400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.45Molecular Weight (Monoisotopic): 370.1264AlogP: 3.37#Rotatable Bonds: 4
Polar Surface Area: 80.04Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.46CX LogP: 2.44CX LogD: 0.40
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.66Np Likeness Score: -1.48

References

1. Yang B, Vasbinder MM, Hird AW, Su Q, Wang H, Yu Y, Toader D, Lyne PD, Read JA, Breed J, Ioannidis S, Deng C, Grondine M, DeGrace N, Whitston D, Brassil P, Janetka JW..  (2018)  Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors.,  61  (3): [PMID:29301085] [10.1021/acs.jmedchem.7b01490]

Source